369 related articles for article (PubMed ID: 35326605)
1. Radiolabeled Antibodies for Cancer Imaging and Therapy.
Parakh S; Lee ST; Gan HK; Scott AM
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326605
[TBL] [Abstract][Full Text] [Related]
2. Radionuclide therapy of cancer with radiolabeled antibodies.
Boerman OC; Koppe MJ; Postema EJ; Corstens FH; Oyen WJ
Anticancer Agents Med Chem; 2007 May; 7(3):335-43. PubMed ID: 17504159
[TBL] [Abstract][Full Text] [Related]
3. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
DeNardo GL
Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
[TBL] [Abstract][Full Text] [Related]
4. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
5. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
6. Development of radioimmunotherapy for the treatment of non-Hodgkin's lymphoma.
Multani P
Int J Hematol; 2002 Dec; 76(5):401-10. PubMed ID: 12512834
[TBL] [Abstract][Full Text] [Related]
7. The role of nuclear medicine in the treatment of non-Hodgkin's lymphoma (NHL).
Bischof Delaloye A
Leuk Lymphoma; 2003; 44 Suppl 4():S29-36. PubMed ID: 15154740
[TBL] [Abstract][Full Text] [Related]
8. History of antibody therapy for non-Hodgkin's lymphoma.
Forero A; Lobuglio AF
Semin Oncol; 2003 Dec; 30(6 Suppl 17):1-5. PubMed ID: 14710396
[TBL] [Abstract][Full Text] [Related]
9. Current status of cancer therapy with radiolabeled monoclonal antibody.
Oriuchi N; Higuchi T; Hanaoka H; Iida Y; Endo K
Ann Nucl Med; 2005 Jul; 19(5):355-65. PubMed ID: 16164191
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy of the Non-Hodgkin's Lymphomas.
Knox SJ
Semin Radiat Oncol; 1995 Oct; 5(4):331-341. PubMed ID: 10717155
[TBL] [Abstract][Full Text] [Related]
11. Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.
DeNardo GL; DeNardo SJ; O'Donnell RT; Kroger LA; Kukis DL; Meares CF; Goldstein DS; Shen S
Clin Lymphoma; 2000 Sep; 1(2):118-26. PubMed ID: 11707820
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.
Chamarthy MR; Williams SC; Moadel RM
Yale J Biol Med; 2011 Dec; 84(4):391-407. PubMed ID: 22180677
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice.
Juweid ME
J Nucl Med; 2002 Nov; 43(11):1507-29. PubMed ID: 12411555
[TBL] [Abstract][Full Text] [Related]
14. Strategies for developing effective radioimmunotherapy for solid tumors.
DeNardo GL; O'Donnell RT; Kroger LA; Richman CM; Goldstein DS; Shen S; DeNardo SJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3219s-3223s. PubMed ID: 10541367
[TBL] [Abstract][Full Text] [Related]
15. Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody.
Shen S; DeNardo GL; Yuan A; Hartmann-Siantar C; O'Donnell RT; DeNardo SJ
Cancer Biother Radiopharm; 2005 Dec; 20(6):662-70. PubMed ID: 16398618
[TBL] [Abstract][Full Text] [Related]
16. Status of radioimmunotherapy in the new millennium.
Imam SK
Cancer Biother Radiopharm; 2001 Jun; 16(3):237-56. PubMed ID: 11471488
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoconjugates for treating cancer: recent advances and current opportunities.
Bourgeois M; Bailly C; Frindel M; Guerard F; Chérel M; Faivre-Chauvet A; Kraeber-Bodéré F; Bodet-Milin C
Expert Opin Biol Ther; 2017 Jul; 17(7):813-819. PubMed ID: 28438082
[TBL] [Abstract][Full Text] [Related]
18. [Systemic radiotherapy using monoclonal antibodies. Options and problems].
Sautter-Bihl ML; Wannenmacher M; Bihl H
Strahlenther Onkol; 1993 Jun; 169(6):358-65. PubMed ID: 8316939
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM; Goldenberg DM
J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
[TBL] [Abstract][Full Text] [Related]
20. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
